SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-18-000037
Filing Date
2018-10-30
Accepted
2018-10-30 08:08:34
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09301810-q.htm 10-Q 968514
2 EXHIBIT 3.1 a093018ex31.htm EX-3.1 216153
3 EXHIBIT 31.1 a093018ex311.htm EX-31.1 14803
4 EXHIBIT 31.2 a093018ex312.htm EX-31.2 14050
5 EXHIBIT 32.1 a093018ex321.htm EX-32.1 11772
12 arraylogo2018a08.jpg GRAPHIC 146580
13 braftovimektovirrgb.jpg GRAPHIC 224279
  Complete submission text file 0001100412-18-000037.txt   6821534

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arry-20180930.xml EX-101.INS 1291696
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20180930.xsd EX-101.SCH 46352
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20180930_cal.xml EX-101.CAL 65904
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20180930_def.xml EX-101.DEF 301234
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20180930_lab.xml EX-101.LAB 642652
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20180930_pre.xml EX-101.PRE 411407
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 181145565
SIC: 2834 Pharmaceutical Preparations